TNFRSF18 Antikörper (AA 1-241)
TNFRSF18
Reaktivität: Human
WB
Wirt: Maus
Polyclonal
unconjugated
-
-
Target
Alle TNFRSF18 Antikörper anzeigen
-
TNFRSF18
(Tumor Necrosis Factor Receptor Superfamily, Member 18 (TNFRSF18))
-
Bindungsspezifität
-
AA 1-241
-
Reaktivität
-
Human
-
Wirt
-
Maus
-
Klonalität
-
Polyklonal
-
Konjugat
-
Dieser TNFRSF18 Antikörper ist unkonjugiert
-
Applikation
-
Western Blotting (WB)
-
Verwendungszweck
-
Mouse polyclonal antibody raised against a full-length human TNFRSF18 protein.
-
Sequenz
-
MAQHGAMGAF RALCGLALLC ALSLGQRPTG GPGCGPGRLL LGTGTDARCC RVHTTRCCRD YPGEECCSEW DCMCVQPEFH CGDPCCTTCR HHPCPPGQGV QSQGKFSFGF QCIDCASGTF SGGHEGHCKP WTDCTQFGFL TVFPGNKTHN AVCVPGSPPA EPLGWLTVVL LAVAACVLLL TSAQLGLHIW QLRSQCMWPR ETQLLLEVPP STEDARSCQF PEEERGERSA EEKGRLGDLW V
-
Kreuzreaktivität
-
Human
-
Produktmerkmale
-
Antibody reactive against mammalian transfected lysate.
-
Immunogen
-
TNFRSF18 (NP_004186, 1 a.a. ~ 241 a.a) full-length human protein.
-
Top Product
-
Discover our top product TNFRSF18 Primärantikörper
-
-
-
Applikationshinweise
-
Optimal working dilution should be determined by the investigator.
-
Beschränkungen
-
Nur für Forschungszwecke einsetzbar
-
-
Format
-
Liquid
-
Buffer
-
No additive
-
Konservierungsmittel
-
Without preservative
-
Handhabung
-
Aliquot to avoid repeated freezing and thawing.
-
Lagerung
-
-20 °C
-
Informationen zur Lagerung
-
Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
Target
-
TNFRSF18
(Tumor Necrosis Factor Receptor Superfamily, Member 18 (TNFRSF18))
-
Andere Bezeichnung
-
TNFRSF18 (TNFRSF18 Produkte)
-
Synonyme
-
GITR antikoerper, TNFRSF18 antikoerper, AITR antikoerper, Gitr antikoerper, CD357 antikoerper, GITR-D antikoerper, TNF receptor superfamily member 18 antikoerper, tumor necrosis factor receptor superfamily, member 18 antikoerper, TNFRSF18 antikoerper, Tnfrsf18 antikoerper
-
Hintergrund
-
Full Gene Name: tumor necrosis factor receptor superfamily, member 18
Synonyms: AITR,GITR,GITR-D
-
Gen-ID
-
8784
-
NCBI Accession
-
NM_004195
-
Pathways
-
Cancer Immune Checkpoints
-